Suppr超能文献

更昔洛韦治疗重症 EBV 肝炎。

Severe EBV hepatitis treated with valganciclovir.

机构信息

Clinical Department, First Division, National Institute for Infectious Diseases "Lazzaro Spallanzani", Via Portuense 292, 00149, Rome, Italy.

出版信息

Infection. 2013 Feb;41(1):251-4. doi: 10.1007/s15010-012-0303-0. Epub 2012 Jul 27.

Abstract

We describe the case of an 18-year-old immunocompetent male patient with severe hepatitis during primary Epstein-Barr virus infection, treated with oral valganciclovir. During the initial therapy with corticosteroids, the patient's clinical condition and liver function worsened, so we decided to add oral valganciclovir for its good bio-availability and previous encouraging experiences in different clinical settings, with rapid resolution of the symptoms.

摘要

我们描述了一例 18 岁免疫功能正常的男性患者,在原发性 EBV 感染期间发生严重肝炎,接受口服缬更昔洛韦治疗。在最初使用皮质类固醇激素治疗期间,患者的临床状况和肝功能恶化,因此我们决定加用口服缬更昔洛韦,因为其生物利用度好,并且在不同临床环境中有令人鼓舞的既往经验,症状迅速缓解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验